Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.83 |
| ▸ | MAPT | P10636 | 5/20 | 0.83 |
| ▸ | NPC1 | O15118 | 5/20 | 0.83 |
| ▸ | RAB9A | P51151 | 5/20 | 0.83 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | RORC | P51449 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | PPARG | P37231 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | PPARA | Q07869 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 2/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7118616 | 0.90 | SMN1; SMN2 (0.67) | SMN1; SMN2MAPTNPC1RAB9APOLB | |
| SCHEMBL18147747 | 0.88 | SMN1; SMN2 (0.64) | SMN1; SMN2MAPTNPC1RAB9APOLB | |
| SCHEMBL7130289 | 0.87 | SMN1; SMN2 (0.66) | SMN1; SMN2MAPTNPC1RAB9ALMNA | |
| SCHEMBL18147642 | 0.86 | SMN1; SMN2 (0.61) | SMN1; SMN2MAPTNPC1RAB9APOLB | |
| SCHEMBL7120764 | 0.81 | KMT2A (0.76) | SMN1; SMN2MAPTNPC1RAB9APOLB | |
| SCHEMBL2585157 | 0.81 | TP53 (0.82) | SMN1; SMN2MAPTNPC1RAB9ALMNA | |
| SCHEMBL26926304 | 0.81 | NPC1 (0.71) | SMN1; SMN2MAPTNPC1RAB9APOLB | |
| SCHEMBL19651332 | 0.80 | KDM4E (0.70) | SMN1; SMN2MAPTNPC1RAB9APOLB | |
| SCHEMBL7048268 | 0.80 | NPC1 (0.82) | SMN1; SMN2MAPTNPC1RAB9APOLB | |
| SCHEMBL7127143 | 0.80 | SMN1; SMN2 (0.66) | SMN1; SMN2MAPTNPC1RAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1440383-A | PPAR gamma modulators | SANKYO CO (JP) | 2003-09-03 | — | — | CN | disclosed |
| US-20030134859-A1 | PPAR-gamma modulator | SANKYO COMPANY, LIMITED (JP) | 2003-07-17 | — | — | US | disclosed |
| EP-1277729-A1 | PPAR (GAMMA) MODULATORS | Sankyo Company, Limited (JP) | 2003-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030134859-A1 | PPAR-gamma modulator | PPARG, PPARA, PPARD | SMN1; SMN2 3743/4885MAPT 4391/4885NPC1 1152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.